What Researchers Did
Researchers conducted a literature review to evaluate current treatment options for osteoradionecrosis (ORN) of the mandible.
What They Found
They found that the fibroatrophic theory is gaining acceptance as a primary mechanism for osteoradionecrosis (ORN), challenging traditional views. While medical management targeting this process shows promise, robust clinical trials are needed, and the routine use of hyperbaric oxygen therapy is not broadly substantiated. There are no gold standard treatments or consensus guidelines, highlighting the need for further quantitative research.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis (ORN) may benefit from evolving medical management strategies targeting the fibroatrophic process, though these require further clinical validation. Treatment decisions will likely remain individualized, considering disease severity and patient characteristics, as there is no single gold standard approach.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
A key limitation is the lack of robust clinical trials and consensus guidelines to definitively confirm the efficacy of emerging treatments for osteoradionecrosis.